ArticleMolecular biology reports2026
miR-4687-3p modulates cell proliferation and migration in cervical cancer cells.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCervical cancer, a public health concern in low-income countries has high mortality in women. miR-4687-3p was downregulated in cervical cancer patients of South Indian region. MicroRNAs are known to alter gene expression in cancers, and the function of miR-4687-3p in cervical cancer is not known.
methodsA combination of in-vitro assays and in-silico bioinformatics analysis was carried out to validate the functional role of miR-4687-3p in cervical cancer. Cervical cancer cells were transfected with miRNA mimics to carry out cell proliferation, migration assays and mRNA sequencing followed by in-silico function enrichment analysis to delineate cancer related pathways.
resultsmiR-4687-3p was downregulated in cervical cancer cell lines. miR-4687-3p overexpression resulted in a decrease in the proliferation and migration of cervical cancer cells. mRNA sequencing analysis showed several cancer related targets for miR-4687-3p. Further gene ontology, pathway and cancer hallmark enrichment analysis indicated that miR-4687-3p might play a role in carcinogenesis. microRNA target analysis identified MYO9B, STAT3, CEACAM1, VEGFB as target genes involved in different cancer hallmarks and STAT3 was considered as the most important target hub gene in the miR-4687-3p mediated gene network.
conclusionUpregulation of miR-4687-3p lead to decrease in the proliferative and migratory capacity of cervical cancer cells. Target and pathway analysis supports the potential role of miR-4687-3p in several cancer related pathways. Altogether the findings suggest miR-4687-3p to be a potential therapeutic target for cervical cancer.
Indexed as
Identifiers
42377617What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.